| Convalescent Plasma in COVID-19 Elderly Patients (NCT04569188) | Azienda Socio Sanitaria Territoriale di Mantova | 2020-05-15 |
| Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (NCT04311697) | APR Applied Pharma Research s.a. | 2020-05-15 |
| Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma (NCT04390958) | Chinese Academy of Medical Sciences | 2020-05-15 |
| Tableted COVID-19 Therapeutic Vaccine (NCT04380532) | Immunitor LLC | 2020-05-15 |
| Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays (NCT04074993) | JI-YOUN HAN | 2020-05-15 |
| 2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter-based Ablation (NCT04433091) | Vanderbilt University Medical Center | 2020-05-15 |
| Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies (NCT04349436) | Replimune, Inc. | 2020-05-15 |
| Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome (NCT04400032) | Ottawa Hospital Research Institute | 2020-05-15 |
| Application of S26E for Diabetic Foot Ulcer Healing (NCT04186377) | National and Kapodistrian University of Athens | 2020-05-15 |
| A Study of PD-1/CTLA-4 Bispecific AK104 in Relapsed or Refractory Peripheral T-cell Lymphoma (NCT04444141) | Akeso | 2020-05-15 |
| A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering (NCT04426669) | Intima Bioscience, Inc. | 2020-05-15 |
| Virtual Patient Behavioral Response Training for Family Caregivers (NCT04489303) | Photozig, Inc. | 2020-05-15 |
| A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials (NCT04362254) | Boehringer Ingelheim | 2020-05-15 |
| Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 (NCT04412538) | Institute of Medical Biology, Chinese Academy of Medical Sciences | 2020-05-15 |
| plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients (NCT04622826) | Azienda USL Toscana Nord Ovest | 2020-05-15 |
| Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial (NCT04399798) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2020-05-15 |
| Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19 (NCT04377997) | Massachusetts General Hospital | 2020-05-15 |
| Chlorhexidine Vaginal Preparation for Reduction of Post-cesarean Endometritis and Sepsis (NCT04385680) | Zagazig University | 2020-05-15 |
| InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort (NCT04379076) | Revimmune | 2020-05-14 |
| Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients (NCT04393675) | Lumosa Therapeutics Co., Ltd. | 2020-05-14 |
| Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection (NCT04357730) | Denver Health and Hospital Authority | 2020-05-14 |
| Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205) (NCT04003610) | Incyte Corporation | 2020-05-14 |
| A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI (NCT04247256) | Scandion Oncology A/S | 2020-05-14 |
| Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) (NCT04363827) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2020-05-14 |
| Improving Quality of Bier Block (NCT04393610) | Assiut University | 2020-05-14 |
| A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19. (NCT04348435) | Hope Biosciences Research Foundation | 2020-05-14 |
| Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy (NCT04326257) | Dan Zandberg | 2020-05-14 |
| Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma (NCT04221555) | Asan Medical Center | 2020-05-13 |
| A Phase 1/2 Study of SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects (NCT04394286) | Baxalta now part of Shire | 2020-05-13 |
| A Study of PCSK9 Inhibitor AK102 in Patients With Hypercholesterolemia (NCT04358432) | Akeso | 2020-05-13 |
| A Phase II Study in Patients With Alopecia Areata (NCT04346316) | Reistone Biopharma Company Limited | 2020-05-13 |
| Safety and Efficacy Study of Human T Lymphoid Progenitor (HTLP) Injection After Partially HLA Compatible Allogeneic Hematopoietic Stem Cell Transplantation in SCID Patients (NCT03879876) | Assistance Publique - Hôpitaux de Paris | 2020-05-13 |
| Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 (NCT04390139) | Banc de Sang i Teixits | 2020-05-13 |
| Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 (NCT04354259) | University Health Network, Toronto | 2020-05-13 |
| Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT03961672) | City of Hope Medical Center | 2020-05-13 |
| Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations (NCT05019794) | LianBio LLC | 2020-05-13 |
| Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (NCT03993262) | Jena University Hospital | 2020-05-13 |
| Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax (NCT04419519) | Memorial Sloan Kettering Cancer Center | 2020-05-13 |
| Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) (NCT04365257) | Johns Hopkins University | 2020-05-13 |
| Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 (NCT04358068) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-05-13 |
| Inhaled Nitric Oxide for Preventing Progression in COVID-19 (NCT04388683) | Tufts Medical Center | 2020-05-12 |
| A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC (NCT04423965) | First Affiliated Hospital of Zhejiang University | 2020-05-12 |
| An Open-label, Randomized, Parallel-arm Study Investigating the Efficacy and Safety of Intravenous Administration of Pamrevlumab Versus Standard of Care in Patients With COVID-19 (NCT05262309) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2020-05-12 |
| Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD) (NCT04465916) | Enyo Pharma | 2020-05-12 |
| Creatine Use and Muscle Stretching in Peripheral Artery Disease (NCT04471792) | Florida State University | 2020-05-12 |
| A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients (NCT04383067) | Sheba Medical Center | 2020-05-12 |
| Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma (NCT04393220) | Fuda Cancer Hospital, Guangzhou | 2020-05-11 |
| Ramipril for the Treatment of COVID-19 (NCT04366050) | University of California, San Diego | 2020-05-11 |
| Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia (NCT04750317) | I.M. Sechenov First Moscow State Medical University | 2020-05-11 |
| Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study (NCT04392505) | Oslo University Hospital | 2020-05-11 |
| A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma (NCT05066802) | Yonsei University | 2020-05-11 |
| Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors (NCT04126070) | Xiao X. Wei, MD | 2020-05-11 |
| Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells (NCT04382547) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2020-05-11 |
| Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer (NCT04267887) | OHSU Knight Cancer Institute | 2020-05-11 |
| Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized Patients (NCT04354831) | Medical College of Wisconsin | 2020-05-11 |
| Pharmacologic Modulation of Hippocampal Activity in Psychosis (NCT04277936) | Vanderbilt University Medical Center | 2020-05-11 |
| Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC (NCT04371796) | Sichuan Cancer Hospital and Research Institute | 2020-05-10 |
| A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone (NCT04158947) | xuexin he | 2020-05-10 |
| Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer (NCT04156087) | Baki Topal | 2020-05-09 |
| Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer (NCT04289792) | Fujian Medical University Union Hospital | 2020-05-09 |
| A Phase I/II Study of TJ004309 for Advanced Solid Tumor (NCT04322006) | TJ Biopharma Co., Ltd. | 2020-05-09 |
| A Study of Anlotinib and AK105 Injection in Subjects With Advanced Head, Neck and Chest Cancer (NCT04203719) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-05-09 |
| Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma (NCT04431089) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2020-05-09 |
| Acupuncture Treatment on Cerebral Blood Flow (NCT04346511) | University of Oklahoma | 2020-05-09 |
| Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications (NCT04374487) | Max Healthcare Insititute Limited | 2020-05-09 |
| A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 (NCT04382040) | MGC Pharmaceuticals d.o.o | 2020-05-08 |
| COLchicine Versus Ruxolitinib and Secukinumab in Open-label Prospective Randomized Trial in Patients With COVID-19 (NCT04403243) | Lomonosov Moscow State University Medical Research and Educational Center | 2020-05-08 |
| Etoposide in Patients With COVID-19 Infection (NCT04356690) | Boston Medical Center | 2020-05-08 |
| Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study (NCT04456530) | The Stone Research Foundation for Sports Medicine and Arthritis | 2020-05-08 |
| Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia (NCT04562792) | Children's Mercy Hospital Kansas City | 2020-05-08 |
| Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer (NCT04395612) | Chongqing University Cancer Hospital | 2020-05-08 |
| Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) (NCT04443881) | Fundacion Miguel Servet | 2020-05-08 |
| Dose-Escalation Study of HTX-034 Following Bunionectomy (NCT04398329) | Heron Therapeutics | 2020-05-08 |
| Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer. (NCT04368273) | Peking University Third Hospital | 2020-05-08 |
| Immunogenicity and Safety of Subunit Vaccine of Plague Vaccine With Two Immunization Regimens (NCT05330624) | Jiangsu Province Centers for Disease Control and Prevention | 2020-05-08 |
| Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection (NCT04337918) | Sanotize Research and Development corp. | 2020-05-08 |
| Hypoactive Sexual Desire Disorder in Males (NCT04002661) | Mohit Khera | 2020-05-08 |
| Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 (NCT04346147) | Hospital Universitario de Fuenlabrada | 2020-05-07 |
| Acetazolamide for the Prevention of Post Operative CSF Leak (NCT04351061) | University of Miami | 2020-05-07 |
| Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study (NCT04384497) | Joakim Dillner | 2020-05-07 |
| A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease. (NCT04515290) | Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd. | 2020-05-07 |
| Subcutaneous Sarilumab vs Placebo in Hospitalized Patients With Respiratory Distress Caused by COVID 19 (NCT07196306) | BayCare Health System | 2020-05-07 |
| A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary) (NCT04521751) | Empros Pharma AB | 2020-05-07 |
| Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure (NCT04352205) | Emory University | 2020-05-07 |
| Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome (NCT04366908) | Maimónides Biomedical Research Institute of Córdoba | 2020-05-07 |
| Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA) (NCT04304820) | National Heart, Lung, and Blood Institute (NHLBI) | 2020-05-07 |
| A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy (NCT04381988) | Memorial Sloan Kettering Cancer Center | 2020-05-07 |
| A Study of ICP-022 in Patients With R/R DLBCL (NCT04438005) | Beijing InnoCare Pharma Tech Co., Ltd. | 2020-05-07 |
| Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19 (NCT04366271) | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | 2020-05-07 |
| BAttLe Against COVID-19 Using MesenchYmal Stromal Cells (NCT04348461) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2020-05-06 |
| Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients (NCT04336254) | Renmin Hospital of Wuhan University | 2020-05-06 |
| Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NCT04285268) | Rutgers, The State University of New Jersey | 2020-05-06 |
| RTX-240 Monotherapy and in Combination With Pembrolizumab (NCT04372706) | Rubius Therapeutics | 2020-05-06 |
| Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early (NCT04398004) | Hellenic Institute for the Study of Sepsis | 2020-05-06 |
| Preemptive Acetaminophen for Postoperative Pain Control Following Minimally Invasive Hysterectomy (NCT04360135) | Montefiore Medical Center | 2020-05-06 |
| A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection (NCT04392232) | TriHealth Inc. | 2020-05-05 |
| NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE (NCT04403269) | Versailles Hospital | 2020-05-05 |
| Convalescent Plasma as a Possible Treatment for COVID-19 (NCT04442191) | University of Illinois at Chicago | 2020-05-05 |
| A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19 (NCT04379492) | Memorial Sloan Kettering Cancer Center | 2020-05-05 |
| Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure (NCT04586088) | Sun Yat-sen University | 2020-05-05 |